SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is seeing significant volatility as market participants weigh conflicting signals between geopolitical risks in the Strait of Hormuz and a shift toward seasonal demand weakness. While some traders are focused on potential supply disruptions driving short-term spikes, others are prioritizing the transition to the shoulder season and anticipating that increased domestic production will ultimately weigh on prices.

Synopsys, Inc. engages in the provision of electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs). It also offers semiconductor intellectual property (IP) products. It operates through the Design Automation and Design IP segments. The Design Automation segment includes silicon design, verification of products and services, and Ansys products, and system integration of products and services. The Design IP segment refers to interface, foundation, security, and embedded processor IP, IP subsystems, and IP implementation services that serve companies primarily in the semiconductor and electronics industries. The company was founded by Aart J. de Geus, Bill Krieger, Dave Gregory, and Rick Rudell in December 1986 and is headquartered in Sunnyvale, CA.

Synopsys, Inc.

Synopsys Inc

Synopsys is drawing significant attention following a $2 billion strategic investment from Nvidia, which reinforces a multi-year partnership to advance AI-driven chip design and engineering workflows. Investors are actively debating the long-term growth potential of this alliance, weighing concerns over share dilution and macroeconomic sensitivity against the company's critical role in the accelerating AI infrastructure build-out.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is gaining significant traction as a critical infrastructure provider in the DeFi and Real World Asset (RWA) space, bolstered by high-profile institutional partnerships and a revenue-sharing model that includes token buybacks. Community discussion centers on its utility as a primary oracle for reliable, institutional-grade financial data, with many participants viewing it as an undervalued asset compared to speculative meme tokens.

Roma Green Finance Ltd. is a holding company, which engages in the provision of environmental, social and governance, sustainability, and climate change related advisory services through its subsidiaries. Its services include corporate and risk advisory, sustainability strategy services, climate risk advisory, ESG reporting services, and sustainable finance. The company was founded in 2018 and is headquartered in Hong Kong.

Roma Green Finance Ltd - Ordinary Shares - Class A

Roma Green Finance Ltd

Roma Green Finance is currently attracting significant community attention as a low-float play, with traders closely monitoring the ticker for sharp momentum spikes and potential volatility halts. Discussion is driven by retail interest in the stock's tendency to react to scanner activity and broader market sentiment regarding small-cap Chinese stocks.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is capturing community attention as investors await the launch of its Super App, which is being touted as a potential catalyst for long-term utility and wider institutional adoption. While some participants are actively accumulating positions and discussing staking opportunities, debate persists regarding the project's price action and the impact of upcoming token unlocks on its market performance.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing a sharp, volatile sell-off, with investors debating whether this price action represents a temporary liquidity-driven liquidation or a fundamental breakdown of gold's safe-haven narrative. The community is actively discussing the impact of hotter-than-expected producer inflation data, a surging US dollar, and rising yields, while others treat the dip as a strategic opportunity to accumulate physical metal amidst ongoing geopolitical uncertainty.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors await a critical Supreme Court decision regarding patent infringement that could reshape 'skinny label' drug regulations. Meanwhile, community sentiment is heavily focused on the company's recent move toward profitability and anticipation that its cash-positive position and intellectual property might attract potential acquisition interest during the J.P. Morgan Healthcare Conference.

SolarEdge Technologies, Inc. engages in the development of energy technology, which provides inverter solutions. The firm operates through the following segments: Solar and All Other. The Solar segment includes the design, development, manufacturing, and sales of an inverter solution designed to maximize power generation. The All Other segment includes the design, development, manufacturing and sales of UPS products, energy storage products, e-Mobility products, and automated machines. Its products and services include photovoltaic inverters, power optimizers, photovoltaic monitoring, software tools, and electric vehicle chargers. The company was founded by Guy Sella, Lior Handelsman, Yoav Galin, Meir Adest, and Amir Fishelov on August 7, 2006 and is headquartered in Herzliya, Israel.

Solaredge Technologies Inc

SolarEdge is experiencing significant volatility driven by a combination of speculative gamma squeezes, short covering, and shifting analyst sentiment regarding the company's long-term profitability and its potential role in AI data center power. The community remains intensely divided, with active debates between bullish traders expecting a sustained breakout and bearish investors highlighting fundamental concerns like negative margins and high levels of debt.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing intense market volatility as investors weigh the company's ambitious joint 'Terafab' chip manufacturing project against concerns over slowing EV demand and broader macroeconomic headwinds. Community sentiment is deeply divided, with some traders optimistic about long-term potential in robotics and AI, while others are aggressively shorting the stock, citing deteriorating fundamentals and legal challenges surrounding the CEO.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile is currently seeing intense trading activity as investors analyze technical signals, recent analyst upgrades, and sector-wide sentiment following leadership changes across the telecom industry. The community is actively debating the stock's support levels while monitoring upcoming earnings and potential long-term growth driven by AI-RAN integration and 5G network expansion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Galectin Therapeutics Highlights Belapectin Data in MASH Cirrhosis KOL Event, Eyes Next Steps

Galectin Therapeutics (NASDAQ:GALT) hosted a virtual key opinion leader (KOL) event to discuss belapectin as a potential treatment for patients with metabolic dysfunction-associated steatohepatitis...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

Galectin Therapeutics Inc. (NASDAQ:GALT) Short Interest Update

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) was the target of a significant drop in short interest during the month of December. As of December 31st, there was short interest totaling...

Galectin Therapeutics (NASDAQ:GALT) CEO Joel Lewis Sells 18,571 Shares

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) CEO Joel Lewis sold 18,571 shares of the business's stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an...

Khurram Jamil Sells 25,499 Shares of Galectin Therapeutics (NASDAQ:GALT) Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) insider Khurram Jamil sold 25,499 shares of the business's stock in a transaction on Monday, January 5th. The shares were sold at an average...

Insider Selling: Galectin Therapeutics (NASDAQ:GALT) CFO Sells 25,732 Shares of Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) CFO Jack Callicutt sold 25,732 shares of the stock in a transaction dated Monday, January 5th. The stock was sold at an average price of...

Joel Lewis Sells 27,731 Shares of Galectin Therapeutics (NASDAQ:GALT) Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) CEO Joel Lewis sold 27,731 shares of Galectin Therapeutics stock in a transaction dated Monday, January 5th. The shares were sold at an...

Galectin Therapeutics (NASDAQ:GALT) CEO Joel Lewis Sells 37,698 Shares

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) CEO Joel Lewis sold 37,698 shares of Galectin Therapeutics stock in a transaction on Tuesday, January 6th. The stock was sold at an average...

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.10	--	--	N/A
Q3 '25	-$0.11	-$0.13	-18.18%	MISSED
Q2 '25	-$0.16	-$0.12	25.00%	BEAT
Q1 '25	-$0.20	-$0.15	25.00%	BEAT
Q4 '24	-$0.16	-$0.19	-18.75%	MISSED

GALT
Galectin Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest GALT News

GALTGalectin Therapeutics Inc